approved EB-1B
Senior Toxicologist / Study Director
Toxicology · India · 2025-11-04
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 2 criteria metScholarly Publications (Met)
The petitioner authored 21 peer-reviewed articles and a book chapter in authoritative international journals.
Original Research Contributions (Met)
The petitioner's work on HMGB1 and respiratory safety provided significant original contributions to the field of toxicology.
Peer Review Judging (Met)
The petitioner's extensive peer-review service confirmed their expertise and trust within the scientific community.
Why This Petition Was Approved
The petition was approved based on 21 peer-reviewed journal articles and a published book chapter that established foundational laboratory methodology. The petitioner demonstrated significant influence with 713 citations and extensive peer-review service. These metrics satisfied the EB-1B criteria for an outstanding researcher with international recognition in the field of toxicology.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Judging Experience
Original Contributions
Government Alignment
Evidence Submitted
- 21 peer-reviewed journal articles (6 as first author)
- 1 published book chapter on laboratory methodology
- 713 citations
- Extensive peer-review service for the scientific community
Similar Cases
Postdoctoral Researcher
Biotechnology · China
WeGreened EB-1B rfe approved
Massachusetts 557 days 2025-10-20
The petition was approved based on the petitioner's 14 peer-reviewed journal articles and 655 citations, which established his international influence in cell biology. His completion of 25 peer reviews for leading journals satisfied the judging criteria for EB-1B. The evidence successfully demonstrated his original scientific research contributions to the field of cancer treatment and molecular biochemistry.
Assistant Professor
Research and Development · India
WeGreened EB-1B approved
7 days 2023-09-25
The petition was approved based on meeting the EB-1B criteria for international recognition as an outstanding researcher. Key metrics included 14 peer-reviewed scientific articles, one book chapter, and 201 citations demonstrating significant influence. Additionally, the petitioner's record of 100 peer reviews for acclaimed journals established his prestige and standing in the field.
Scientist
Biotechnology · India
WeGreened EB-1B approved
Washington 14 days 2025-08-12
The petition was approved based on 12 peer-reviewed journal articles and 647 citations demonstrating significant influence. The petitioner also provided evidence of 10 manuscript reviews and research funding from prestigious institutions like the NIH. These metrics satisfied the EB-1B criteria for scholarly publications, original contributions, and peer review.
Assistant Professor
Healthcare · China
WeGreened EB-1B rfe approved
560 days 2026-01-13
Approval was granted based on a strong record of 16 peer-reviewed articles and 15 abstracts with 96 citations, demonstrating international recognition. The petitioner satisfied EB-1B criteria through original research contributions, authorship of scholarly articles, and participation as a judge of the work of others via 37 peer reviews and two editorial board memberships.
Frequently Asked Questions
A approved EB-1B (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-11-04.
Browse all casesAt a Glance
Outcome approved
Processing 12 days
Criteria Met 3 / 2
Evidence Types 5
EB-1B Case Data
Scraped Case Data
Total Cases 63
Success Rate 98.4%
Sustained 62
Dismissed 1
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist